Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-380-0 | CAS number: 53126-67-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test item was not mutagenic in the bacterial reverse mutation assay.
The read across-substance (CAS 107-66-4) was not clastogenic in the chromosome aberration study and it was not mutagenic in vitro in mammalian cells.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1979
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only one experiment was performed
- GLP compliance:
- not specified
- Remarks:
- study conducted before GLP was introduced
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- test material: Da7934/3 - Target gene:
- histidine operon
- Species / strain / cell type:
- other: Salmonella typhimurium TA1535, TA1537; TA1538; TA100 and TA98
- Additional strain / cell type characteristics:
- other: histidine and biotine auxotrophic, rfa and uvrB character
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9-mix, Aroclor 1254 induced
- Test concentrations with justification for top dose:
- 0, 10, 25, 100, 250, 1000, 2500 µg/plate
- Vehicle / solvent:
- - Vehicle/solvent used: DMSO
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- methylmethanesulfonate
- other: 2 -aminofluorene (with S9 mix, all strains), ethylmethansulfonate (all strains)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3
NUMBER OF CELLS EVALUATED: all revertant colonies
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- A reversion rate at least two-fold higher than the spontaneous reversion rate of the respective strain is considered as a positive mutation test result.
- Statistics:
- not necessary
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not valid
- Positive controls validity:
- valid
- Additional information on results:
RANGE-FINDING/SCREENING STUDIES:
A study was performed to assess the cytotoxic property of the test item at 2500 µg/plate or lower. No cytotoxic property was revealed at the tested concentrations.- Conclusions:
- The test item was not mutagenic in the bacterial reverse mutation assay.
- Executive summary:
An Ames test was conducted with the test item in five strains of Salmonella typhimurium: TA98, TA100, TA1535, TA1537, TA1538. The substance was tested at the following concentrations: 0, 10, 25, 100, 250, 1000, 2500 µg/plate, with and without metabolic activation (Aroclor 1254 induced rat liver S9-mix). DMSO served as vehicle. The positive control substances 2-aminofluorene, methylmethanesulfonate, ethylmethanesulfonate and 9-aminoacridine led to revertant colony counts clearly exceeding a two-fold increase over the spontaneous mutation rate of each strain and therefore a positive mutation result. The revertant colony counts of the test item treated plates were below the fold increase of the spontaneous mutation rate. Therefore, the substance was considered to be not mutagenic in this assay.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1979
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only one experiment was performed, only one bacterial strain tested
- GLP compliance:
- not specified
- Remarks:
- study conducted before GLP was introduced
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- test material: Da7934/3 - Target gene:
- trp operon
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- other: tryptophan auxotrophic, uvrA character
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9-mix, Aroclor 1254 induced
- Test concentrations with justification for top dose:
- 0, 10, 25, 100, 250, 1000, 2500 µg/plate
- Vehicle / solvent:
- - Vehicle/solvent used: DMSO
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- other: dimethylnitrosamine (with S9-mix)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3
NUMBER OF CELLS EVALUATED: all revertant colonies
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- A reversion rate at least two-fold higher compared to the spontaneous reversion rate is considered as a positive mutation test result.
- Statistics:
- not necessary
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not valid
- Positive controls validity:
- valid
- Additional information on results:
RANGE-FINDING/SCREENING STUDIES:
A study was performed to assess the cytotoxic property of the test item at 2500 µg/plate or lower. No cytotoxic property was revealed at the tested concentrations.- Conclusions:
- The test item was not mutagenic in the bacterial reverse mutation assay in the E. coli strain WP2 uvrA..
- Executive summary:
An Ames test was conducted with the test item in the E.coli strain WP2 uvrA. The substance was tested at the following concentrations: 0, 10, 25, 100, 250, 1000, 2500 µg/plate, with and without metabolic activation (Aroclor 1254 induced rat liver S9-mix). DMSO served as vehicle. The positive control substances methylmethanesulfonate and dimethylnitrosamine led to revertant colony counts clearly exceeding a two-fold increase over the spontaneous mutation rate and therefore a positive mutation result. The revertant colony counts of the test item treated plates were below the fold increase of the spontaneous mutation rate. Therefore, the substance was considered to be not mutagenic in this assay.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2008-06-20 to 2008-09-09
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: cHA0044776
- Expiration date of the lot/batch: April 07, 2009 - Target gene:
- histidine locus
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Additional strain / cell type characteristics:
- other: besides being histidine auxotrophic, the strains of S. typhimurium carry an additional rfa mutation and are deficient in DNA excision repair. Strain WP2 uvrA is defective in tryptophan biosynthesis and deficient in DNA excision repair.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/p-Naphthoflavone induced rat liver S9 mix
- Test concentrations with justification for top dose:
- ln the pre-experiment the concentration range of the test item was 3 - 5000 pµg/plate. The pre-experiment is reported as experiment I. Since no toxic effects were observed 5000 µg/plate were chosen as maximal concentration. The concentration range included two logarithmic decades. The following concentrations were tested in experiment ll: 33; 100; 333; 1000; 2500; and 5000 µg/plate.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubility properties. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine (without metabolic activation, strains TA 1537, TA 98); 2-aminoanthracene (all strains, with metabolic activation)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: Experiment I: in agar (plate incorporation); Experiment II: preincubation
DURATION
- Preincubation period: in the preincubation assay (Experiment II): 60 min
- Exposure duration: 48 h
- Expression time (cells in growth medium): 48 h (+ 1 h if preincubated)
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Rationale for test conditions:
- according to Guideline
- Evaluation criteria:
- A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- According to the OECD guideline 471, a statistical analysis of the data is not mandatory.
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Minor toxic effects were observed in experiment ll without metabolic activation at 5000 µg/plate.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Minor toxic effects were observed in experiment ll without metabolic activation at 5000 µg/plate.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Minor toxic effects were observed in experiment ll without metabolic activation at 5000 µg/plate.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no effects observed
- Effects of osmolality: no effects observed
- Precipitation: no precipitation observed - Conclusions:
- The test item was not mutagenic in the bacterial reverse mutation assay.
- Executive summary:
The test item was assessed for its potential to induce gene mutations in the plate incorporation test (experiment l) and the pre-incubation test (experiment ll) using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100, and the Escherichia coli strain WP2 uvrA. The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test item was tested at the following concentrations:
Pre-Experiment/Experiment l: 3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate
Experiment ll: 33; 100; 333; 1000; 2500; and 5000 µg/plate
The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without metabolic activation in experiment I. Reduced background growth was observed in experiment ll without metabolic activation at 5000 µg/plate in strains TA 1535, TA 1537, and TA 100. No toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in experiment I with and without metabolic activation. Minor toxic effects were observed in experiment ll without metabolic activation in strains TA 1535, TA 1537, and TA 100 at 5000 µg/plate. No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). Appropriate reference mutagens were used as positive controls. They showed a distinct increase of induced revertant colonies. ln conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to the attached read-across justification in section 13. - Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- inhibition was observed at 156.2 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- inhibition was observed at 156.2 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- inhibition was observed at 156.2 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- inhibition was observed at 156.2 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- inhibition was observed at 156.2 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- The test substance was not mutagenic in the bacterial reverse mutation assay.
- Executive summary:
The mutagenicity of the test substance was investigated by means of a reverse mutation study using bacteria. The bacteria used wereSalmonella typhimuriumTA100, TA1535, TA98 and TA1537, andEscherichia coliWP2uvrA. The following concentrations were used ( with and without metabolic activation, phenobarbital (PB) and 5,6-benzoflavone (BF) induced rat liver S9-mix):0, 4.882, 9.765, 19.53, 39.06, 78.12, 156.2 µg/plate. In the assay, 3 negative control plates, 3 positive control plates and 3 plates per dose were used. The assay was undertaken twice, and no increase in the number of revertant colonies was observed at any dose, for any of the 5 types of bacteria used. In the positive control group, an increase in the number of revertant colonies was observed for all bacteria used, and in the negative control group the total number of revertant colonies was within historical control values. The test item was deemed to have no mutagenic potential in the test systems used.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to the attached read-across justification in section 13. - Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 1997
- Deviations:
- no
- Key result
- Species / strain:
- other: Chinese hamster CHL
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- 50 % growth inhibition was observed in Experiment I at 0.24 mg/mL, and at 0.54 mg/mL (with S9 mix) and 0.41 mg/mL (without S9 mix) in Experiment II
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- The read across-substance was found to have no clastogenic potential in this assay.
- Executive summary:
The clastogenic potential of the test item was investigated using cultured Chinese hamster (CHL) cells. In the direct method (Experiment I), a concentration of 0.24 mg/mL afforded approximately 50 % growth inhibition. In the metabolic activation method, concentrations of 0.54 mg/mL and 0.41 mg/mL afforded approximately 50 % growth inhibition, in the presence of S9 mix and without S9 mix, respectively. In the chromosome aberration test, therefore, the high concentrations were 0.24 mg/mL for the direct method, 0.54 mg/mL for the metabolic activation method in the presence of S9 mix, and 0.41 mg/mL for the metabolic activation method without S9 mix; the middle concentrations were half, and the low concentrations one quarter, the respective high concentrations. CHL cells were treated for 24 hours and 48 hours in the direct method, and no chromosome structure aberration or polyploidy inducing effects were observed in any of the treated groups. In the metabolic activation method, at the maximum treatment concentration (0.41 mg/mL) without S9 mix there was mitotic inhibition, and so chromosome analysis was not possible. No chromosome structure aberration or polyploidy inducing effects were observed in the other concentration groups, or in any of the groups treated in the presence of S9 mix. The test item did not induce chromosome structure aberration or polyploidy in CHL cells in any of the treatment groups on treatment for 24 hours (0.06-0.24 mg/mL) or on treatment for 48 hours (0.06-0.24 mg/mL) by the direct method. Furthermore, no chromosome structure aberration or polyploidy inducing effects were observed in the metabolic activation method, either in the presence of S9 mix (0.14-0.54 mg/mL) or without S9 mix (0.10-0.21 mg/mL). It was therefore concluded that the test item does not induce chromosome aberration under the test conditions described above. Using positive controls, cells with structure aberrations such as chromatid exchange and chromatic break were observed at high frequency in the mitomycin C treated group in the direct method, and in the cyclophosphamide treated group in the presence of S9 mix.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to the attached read-across justification in section 13. - Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Relevant cytotoxic effects were only noted at the maximum concentration of the first experiment without metabolic activation.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
Referenceopen allclose all
Table 1: Number of revertants per plate (mean of three plates),
strain TA 1535 |
strain TA 1537 |
Strain TA 1538 |
strain TA 100 |
strain TA 98 |
||||||
conc. [µg] per plate |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
2500 |
10 |
8 |
5 |
3 |
13 |
6 |
76 |
68 |
12 |
13 |
1000 |
6 |
6 |
6 |
6 |
12 |
10 |
74 |
66 |
10 |
14 |
250 |
9 |
7 |
4 |
3 |
12 |
8 |
77 |
68 |
16 |
15 |
100 |
9 |
11 |
7 |
5 |
12 |
6 |
80 |
75 |
15 |
12 |
25 |
8 |
9 |
5 |
4 |
13 |
8 |
76 |
77 |
15 |
10 |
10 |
7 |
10 |
4 |
5 |
12 |
7 |
79 |
65 |
12 |
13 |
0 |
8 |
8 |
6 |
4 |
13 |
7 |
79 |
71 |
13 |
13 |
2-aminofluorene 10 µg |
14 |
|
35 |
|
>1000 |
|
>1000 |
|
>1000 |
|
methylmethansulfonate 1000 µg |
|
13 |
|
6 |
|
15 |
|
>1000 |
|
25 |
ethylmethansulfonate 5000 µg |
|
>1000 |
|
5 |
|
22 |
|
>1000 |
|
25 |
2-Aminoacridine 10 µg |
|
13 |
|
291 |
|
14 |
|
140 |
|
18 |
Table 1: Number of revertants per plate (mean of three plates),
E. coli WP2 uvrA |
||
conc. [µg] per plate |
+MA |
-MA |
2500 |
24 |
20 |
1000 |
26 |
25 |
250 |
25 |
25 |
100 |
27 |
22 |
25 |
22 |
22 |
10 |
31 |
18 |
0 |
26 |
25 |
methylmethansulfonate 1000 µg |
|
212 |
dimethylnitrosamine 5000 µg |
397 |
11 |
Table 1: Number of revertants per plate (mean of three plates), Experiment I
strain TA 1535 |
strain TA 1537 |
Strain TA 98 |
strain TA 100 |
strain WP2 uvrA |
||||||
conc. [µg] per plate |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
water |
12 |
12 |
14 |
12 |
39 |
44 |
167 |
162 |
60 |
81 |
untreated |
10 |
13 |
15 |
12 |
33 |
42 |
158 |
143 |
62 |
65 |
Test item 3 µg |
13 |
14 |
15 |
15 |
36 |
51 |
144 |
162 |
56 |
65 |
Test item 10 µg |
12 |
12 |
16 |
14 |
39 |
41 |
165 |
161 |
56 |
77 |
Test item 33 µg |
12 |
12 |
15 |
14 |
38 |
50 |
144 |
152 |
75 |
73 |
Test item 100 µg |
13 |
14 |
15 |
14 |
35 |
41 |
144 |
164 |
68 |
75 |
Test item 333 µg |
12 |
13 |
14 |
15 |
33 |
49 |
160 |
153 |
69 |
71 |
Test item 1000 µg |
10 |
11 |
13 |
16 |
42 |
44 |
136 |
148 |
71 |
68 |
Test item 2500 µg |
9 |
9 |
11 |
15 |
29 |
36 |
124 |
157 |
64 |
75 |
Test item 5000 µg |
7 |
10 |
7 |
12 |
26 |
42 |
82 |
132 |
67 |
71 |
Sodium azide 10 µg |
1795 |
|
|
|
|
|
1975 |
|
|
|
4-NOPD 10 µg |
|
|
|
|
475 |
|
|
|
|
|
4-NOPD 50 µg |
|
|
132 |
|
|
|
|
|
|
|
MMS 3 µg |
|
|
|
|
|
|
|
|
1336 |
|
2-Aminoanthracene 2.5 µg |
|
488 |
|
261 |
|
1840 |
|
1828 |
|
|
2-Aminoanthracene 10 µg |
|
|
|
|
|
|
|
|
|
358 |
Table 2: Number of revertants per plate (mean of three plates), Experiment II
strain TA 1535 |
strain TA 1537 |
Strain TA 98 |
strain TA 100 |
strain WP2 uvrA |
||||||
conc. [µg] per plate |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
water |
23 |
23 |
9 |
18 |
34 |
43 |
144 |
173 |
43 |
52 |
untreated |
19 |
22 |
10 |
18 |
36 |
46 |
160 |
166 |
41 |
52 |
Test item 33 µg |
23 |
24 |
12 |
19 |
34 |
50 |
135 |
164 |
42 |
63 |
Test item 100 µg |
19 |
30 |
13 |
20 |
34 |
44 |
116 |
173 |
45 |
61 |
Test item 333 µg |
23 |
20 |
13 |
16 |
39 |
46 |
132 |
170 |
44 |
60 |
Test item 1000 µg |
21 |
23 |
12 |
18 |
32 |
43 |
107 |
159 |
45 |
57 |
Test item 2500 µg |
11 |
19 |
9 |
13 |
34 |
40 |
71 |
154 |
40 |
51 |
Test item 5000 µg |
6 |
15 |
2 |
10 |
26 |
34 |
39 |
109 |
44 |
48 |
Sodium azide 10 µg |
1797 |
|
|
|
|
|
1987 |
|
|
|
4-NOPD 10 µg |
|
|
|
|
666 |
|
|
|
|
|
4-NOPD 50 µg |
|
|
128 |
|
|
|
|
|
|
|
MMS 3 µg |
|
|
|
|
|
|
|
|
288 |
|
2-Aminoanthracene 2.5 µg |
|
190 |
|
113 |
|
1108 |
|
1459 |
|
|
2-Aminoanthracene 10 µg |
|
|
|
|
|
|
|
|
|
354 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Ames test:
The test item was assessed for its potential to induce gene mutations in the plate incorporation test (experiment l) and the pre-incubation test (experiment ll) using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100, and the Escherichia coli strain WP2 uvrA. The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test item was tested at the following concentrations:
Pre-Experiment/Experiment l: 3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate
Experiment ll: 33; 100; 333; 1000; 2500; and 5000 µg/plate
The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without metabolic activation in experiment I. Reduced background growth was observed in experiment ll without metabolic activation at 5000 µg/plate in strains TA 1535, TA 1537, and TA 100. No toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in experiment I with and without metabolic activation. Minor toxic effects were observed in experiment ll without metabolic activation in strains TA 1535, TA 1537, and TA 100 at 5000 µg/plate. No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). Appropriate reference mutagens were used as positive controls. They showed a distinct increase of induced revertant colonies. ln conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
A further Ames test was conducted with the test item in five strains of Salmonella typhimurium: TA98, TA100, TA1535, TA1537, TA1538. The substance was tested at the following concentrations: 0, 10, 25, 100, 250, 1000, 2500 µg/plate, with and without metabolic activation (Aroclor 1254 induced rat liver S9-mix). DMSO served as vehicle. The positive control substances 2-aminofluorene, methylmethanesulfonate, ethylmethanesulfonate and 9-aminoacridine led to revertant colony counts clearly exceeding a two-fold increase over the spontaneous mutation rate of each strain and therefore a positive mutation result. The revertant colony counts of the test item treated plates were below the fold increase of the spontaneous mutation rate. Therefore, the substance was considered to be not mutagenic in this assay.
In addition to the above mentioned Ames test, a test was conducted with the test item in the E.coli strain WP2 uvrA. The substance was tested at the following concentrations: 0, 10, 25, 100, 250, 1000, 2500 µg/plate, with and without metabolic activation (Aroclor 1254 induced rat liver S9-mix). DMSO served as vehicle. The positive control substances methylmethanesulfonate anddimethylnitrosamine led to revertant colony counts clearly exceeding a two-fold increase over the spontaneous mutation rate and therefore a positive mutation result. The revertant colony counts of the test item treated plates were below the fold increase of the spontaneous mutation rate. Therefore, the substance was considered to be not mutagenic in this assay.
Read across study (Ames)
The mutagenicity of the read across substance was investigated by means of a reverse mutation study using bacteria. The bacteria used wereSalmonella typhimuriumTA100, TA1535, TA98 and TA1537, andEscherichia coliWP2uvrA. The following concentrations were used ( with and without metabolic activation, phenobarbital (PB) and 5,6-benzoflavone (BF) induced rat liver S9-mix):0, 4.882, 9.765, 19.53, 39.06, 78.12, 156.2 µg/plate. In the assay, 3 negative control plates, 3 positive control plates and 3 plates per dose were used. The assay was undertaken twice, and no increase in the number of revertant colonies was observed at any dose, for any of the 5 types of bacteria used. In the positive control group, an increase in the number of revertant colonies was observed for all bacteria used, and in the negative control group the total number of revertant colonies was within historical control values. The read across-substance was deemed to have no mutagenic potential in the test systems used.
Read across (Chromosome aberration)
The clastogenic potential of the read across-substance was investigated using cultured Chinese hamster (CHL) cells. In the direct method (Experiment I), a concentration of 0.24 mg/mL afforded approximately 50 % growth inhibition. In the metabolic activation method, concentrations of 0.54 mg/mL and 0.41 mg/mL afforded approximately 50 % growth inhibition, in the presence of S9 mix and without S9 mix, respectively. In the chromosome aberration test, therefore, the high concentrations were 0.24 mg/mL for the direct method, 0.54 mg/mL for the metabolic activation method in the presence of S9 mix, and 0.41 mg/mL for the metabolic activation method without S9 mix; the middle concentrations were half, and the low concentrations one quarter, the respective high concentrations. CHL cells were treated for 24 hours and 48 hours in the direct method, and no chromosome structure aberration or polyploidy inducing effects were observed in any of the treated groups. In the metabolic activation method, at the maximum treatment concentration (0.41 mg/mL) without S9 mix there was mitotic inhibition, and so chromosome analysis was not possible. No chromosome structure aberration or polyploidy inducing effects were observed in the other concentration groups, or in any of the groups treated in the presence of S9 mix. The read across-substance did not induce chromosome structure aberration or polyploidy in CHL cells in any of the treatment groups on treatment for 24 hours (0.06-0.24 mg/mL) or on treatment for 48 hours (0.06-0.24 mg/mL) by the direct method. Furthermore, no chromosome structure aberration or polyploidy inducing effects were observed in the metabolic activation method, either in the presence of S9 mix (0.14-0.54 mg/mL) or without S9 mix (0.10-0.21 mg/mL). It was therefore concluded that the read across-substance does not induce chromosome aberration under the test conditions described above. Using positive controls, cells with structure aberrations such as chromatid exchange and chromatic break were observed at high frequency in the mitomycin C treated group in the direct method, and in the cyclophosphamide treated group in the presence of S9 mix.
Read across (HPRT):
The study was performed to investigate the potential of the read across substance (CAS: 107 -66 -41) to induce gene mutations at the HPRT locus in V79 cells of the Chinese hamster according to OECD guideline 476. The assay was performed in two independent experiments, using two parallel cultures each. The first main experiment was performed with and without liver microsomal activation and a treatment period of 4 hours. The second experiment was performed with a treatment time of 4 hours with and 24 hours without metabolic activation. The highest concentration of 2200 µg/mL was equal to approximately 10 mM. No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments. Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system. In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, the test item was negative in this HPRT assay.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. As a result the substance is not considered to be classified for genetic toxicity under Regulation (EC) No 1272/2008, as amended for the twelth time in Regulation (EU) No 2019/521.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.